DRAFT AND ATTORNEY-CLIENT PRIVILEGED

First Page		Document Content
Date: 2015-05-01 12:06:40 Pharmaceutical industry Health Medical statistics Clinical trials ClinicalTrials.gov Regulatory requirement Data sharing Celgene Research Clinical research Science		DRAFT AND ATTORNEY-CLIENT PRIVILEGED Add to Reading List Source URL: www.celgene.com Download Document from Source Website File Size: 37,91 KB Share Document on Facebook

	Celgene Blue-EPS- NEW.eps DocID: 1tXF2 - View Document
	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use REVLIMID® safely and effectively. See full prescribing information for REVLIMID. REVLIMID [lenalidomide] capsules, DocID: 1tonS - View Document
	Celgene IncMississauga Road Suite 600 Mississauga, ON L5N 7Y2 Tel: Toll-free: DocID: 1thuA - View Document
	Celgene IncMississauga Road Suite 600 Mississauga, ON L5N 7Y2 Tel: Toll-free: DocID: 1tgVI - View Document
	Celgene IncMississauga Road Suite 600 Mississauga, ON L5N 7Y2 Tél. : Sans frais : DocID: 1t2Vj - View Document